Long-Lasting Remissions for Myeloma Patients on Daratumumab Therapy from the GEN501 and GEN503 Trials

Agoston Gyula Szabo, Monique C. Minnema, Hareth Nahi, Torben Plesner

Research output: Contribution to journal › Conference abstract in journal › Research

Original language	English
Journal	Blood
Volume	132
Issue number	Suppl. 1
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2018-99-111095
Publication status	Published - 29. Nov 2018
Event	60th ASH Annual Meeting - San Diego, United States Duration: 1. Dec 2018 → 4. Dec 2018

Documents & Links

@article{2d427fa86f1040c4b9763334ea89229d,

title = "Long-Lasting Remissions for Myeloma Patients on Daratumumab Therapy from the GEN501 and GEN503 Trials",

author = "Szabo, {Agoston Gyula} and Minnema, {Monique C.} and Hareth Nahi and Torben Plesner",

year = "2018",

month = nov,

day = "29",

doi = "10.1182/blood-2018-99-111095",

language = "English",

volume = "132",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "Suppl. 1",

note = "60th ASH Annual Meeting ; Conference date: 01-12-2018 Through 04-12-2018",

}

TY - ABST

T1 - Long-Lasting Remissions for Myeloma Patients on Daratumumab Therapy from the GEN501 and GEN503 Trials

AU - Szabo, Agoston Gyula

AU - Minnema, Monique C.

AU - Nahi, Hareth

AU - Plesner, Torben

PY - 2018/11/29

Y1 - 2018/11/29

U2 - 10.1182/blood-2018-99-111095

DO - 10.1182/blood-2018-99-111095

M3 - Conference abstract in journal

SN - 0006-4971

VL - 132

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 60th ASH Annual Meeting

Y2 - 1 December 2018 through 4 December 2018

ER -